SciClone Pharmaceuticals Inc. (SCLN) announced that it has appointed Hong Zhao as its Chief Executive Officer, China Operations. Zhao has more than 20 years of experience in leading the commercial operations, market expansion and growth of multi-national companies in China.
Zhao joins SciClone from Simcere Pharmaceutical Group, where he served as Executive Vice President, responsible for all business operations. Prior to Simcere, he held positions of increasing seniority at Novartis China, from Regional Sales Manager, National Sales Director, Vice President, Senior Vice President of Novartis Greater China and General Manager of Novartis Shanghai.
Zhao also served with Xi'an Janssen Pharmaceutical, where he rose quickly from Medical Representative to District Sales Manager. Earlier in his career he served as a lecturer and tutor at Nanjing Medical College.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.